As the key point in PI3K pathway, expression of PI3K plays a critical role in activity of the pathway, which is closely related with the initiation and development of NSCLC, furthermore with the response of tumor to target treatment. This evidence concerns the gene PIK3CB and non-small cell lung carcinoma.